CD44 and ovarian cancer: TRX-E-002-1 is able to induce cell death in chemo-resistant CD44+/MyD88+ OCSC clones (Table 1) and chemo-sensitive CD44−/MyD88− ovarian cancer cell lines when grown separately or in co-cultures which mimic tumour heterogeneity.